Skip to main content

McKesson’s $37M West Virginia Opioid Lawsuit Settlement

McKesson’s $37M West Virginia Opioid Lawsuit Settlement

McKesson’s $37M West Virginia Opioid Lawsuit Settlement

Introduction

The West Virginia Attorney General, Patrick Morrisey, announced that McKesson Corp. has agreed to pay $37 million to resolve claims that the company fueled the opioid epidemic. The drug distributor will pay $14.5 million this year followed by five more annual payments of $4.5 million until 2024. This is believed to be one of the biggest settlements against a distributor. The lawsuit was filed in 2016 in a West Virginia circuit court which stated McKesson shipped millions of doses of both oxycodone and hydrocodone between 2007 and 2012 along with large amounts of other narcotics illegally. In 2017, McKesson agreed to pay a $150 million penalty to settle the violations of the Controlled Substances Act.

The recent West Virginia settlement follows the $270 million deal Purdue Pharma struck in March with the state of Oklahoma to exit the opioid lawsuit crisis. There are more than 1,600 cases over the opioid crisis, filed largely by local governments, Native American tribes, and hospitals. The first trial in the MDL No. 2804 is set to start in October 2019.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!